References
- Krolewski A S., Kosinski E J., Warram J H., et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59: 750–5
- Falke P, Mattiasson I, Stavenow L. Effects of platelets from men with risk factors for atherosclerosis on endothelial cell proliferation and prostacyclin production in vitro. Scand J Clin Lab Invest 1993; 53: 297–303
- Falke P, Lindgärde F, Stavenow L. Differences in blood viscosity, glycosylated hemoglobin and platelet count between male patients with carotid transient ischemic attacks and minor strokes. Clin Hemorheol 1991; 11: 35–40
- Stavenow L, Falke P, Berglund A. Effects of different injurious stimuli on cell death, proliferation and collagen secretion by rabbit smooth muscle cells and umbilical vein endothelial cells in culture. Med Biol 1983; 61: 214–28
- Stavenow L, Kjellström T, Malmqvist J. Effects of LDL from smokers and non-smokers on cell mass proliferation and collagen secretion by rabbit smooth muscle cells and human skin fibroblasts in culture. Med Biol 1982; 60: 144–8
- Stavenow L, Kjellström T, Malmqvist J. Stimulation of collagen production in growth-arrested myocytes and fibroblasts in culture by growth factor(s) from platelets. Exp Cell Res 1981; 136: 321–5
- Falke P, Mattiasson I, Stavenow L, Hood B. Effects of a competitive inhibitor (mevinolin) of 3-hydroxymethylgIutaryl coenzyme A reductase on human and bovine endothelial cells, fibroblasts and smooth muscle cells in vitro. Pharmacol Toxicol 1989; 64: 173–6
- Hartree E F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 1972; 48: 422–7
- Toth L, Szenasi P, Jambor G, Kammerer L, Romics L. Platelet function in male diabetics with and without macrovascular complications. Diabetes Res Clin Pract 1992; 15: 143–8
- Koert M, Novak-Gottl U, Kreuz W, Gruttner H P., Kornhuber B, Breddin H K. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period). Klin Pediatr 1991; 203: 429–32
- Ratzman K P., Schimke E, Beitz A, Hildebrandt R, Taube C. Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications. Klin Wochenschr 1991; 69: 652–6
- Samal K K., Sahu C S., Nanda R C. Platelet adhesiveness in diabetes mellitus in relation to treatment. J Indian Med Assoc 1991; 89: 155–7
- Xu C B., Stavenow L, Pessah-Rasmussen H. Interactions between cultured bovine arterial endothelial and smooth muscle cells; studies on the release of prostacyclin by endothelial cells. Artery 1992; 19: 94–111
- Collier A, Watson H H., Patrick A W., Ludlam C A., Clarke B F. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetes Metab 1989; 15: 420–5
- Ross R, Glomset J, Kariya B, Harker L. A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci 1974; 71: 1207–10
- Oka Y, Orth D N. Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest 1983; 72: 249–59
- Assoian R K., Komoriya A, Meyers C A., Miller D M., Sporn M B. Transforming growth factor beta in human platelets; identification of a major storage site, purification and characterization. J Biol Chem 1983; 258: 7155–60
- Porta M, La Selva, Molinatti P A. Von Willebrand factor and endothelial abnormalities in diabetic microangiopathy. Diabetes Care 1991; 14: 167–72